Acrivon Therapeutics, Inc. Common Stock (ACRV)
Healthcare
Biotechnology
1.60 $
+4.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Acrivon Therapeutics, Inc. Common Stock (ACRV) with date, type and a link to the original document.
No SEC filings are available for this stock yet.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.